SANOFI SAYS DUPIXENT GRANTED EUROPEAN UNION APPROVAL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Sanofi Says Dupixent Granted European Union Approval To Treat…
![Reuters logo](/images/reuters.jpg)
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
90.71 EUR | +0.30% |
|
-0.07% | +1.08% |
08:04am | Sanofi: approval of Dupixent for COPD in the EU | CF |
07:45am | Sanofi obtains EU approval for Dupixent | RE |
SANOFI SAYS DUPIXENT GRANTED EUROPEAN UNION APPROVAL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
1st Jan change | Capi. | |
---|---|---|
+1.11% | 121B | |
+55.55% | 816B | |
+42.31% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+14.02% | 238B | |
+1.64% | 222B | |
+13.66% | 218B | |
+7.87% | 167B |